Göppner D, Müller J, Krüger S, Franke I, Gollnick H, Quist SR. High Incidence of Naevi-associated BRAF Wild-type Melanoma and Dysplastic Naevi under Treatment with the Class I BRAF Inhibitor Vemurafenib. Acta Derm Venereol [Internet]. 2014 Feb. 13 [cited 2024 Dec. 3];94(5):517-20. Available from: https://medicaljournalssweden.se/actadv/article/view/6411